Two big drugmakers and one small biotech appear to be great picks right now.
Lilly Wachowski expresses pleasure that the film’s ‘original intention’ has become commonplace understanding among fans
Lilly Wachowski - who directed the blockbuster franchise The Matrix alongside her sister Lana Wachowski - has explained how the trilogy is a 'trans story.'
The trials, called ACTIV-2 and ACTIV-3, will look at U.S. drugmaker Eli Lilly's experimental treatment known as LY-CoV555, which is being developed in partnership with Canadian biotech AbCellera.
Should you go with the nimble biotech or the big pharmaceutical company?
Incyte Reports 2020 Second Quarter Financial Results and Provides Updates on Key Clinical Programs
The U.S. reported more than 47,000 new coronavirus cases, the smallest daily increase in almost four weeks, despite signs of an uptick in new infections in some Northeast and Midwest states.
The major averages started the new month on a high note as tech shares outperformed.
Lilly's drug, which it is testing in nursing homes and assisted-living facilities, is the lead antibody from its collaboration with AbCellera.
The company said it had begun a Phase 3 trial of up to 2,400 residents and staff who live or work at a nursing home that has recently had a case of Covid-19.
The coronavirus has infected more than 18.1 million people around the world as of Thursday, killing at least 689,922 people.
Shares of Eli Lilly & Co. undefined gained 1.1% in premarket trading on Monday after the drugmaker said it started a Phase 3 trial for a treatment that aims...
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE